Clinical Trial Update: A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients [Phase 3]

View source ↗

Summary

A Phase 3 prospective study evaluating bevacizumab with or without microbubble-mediated focused ultrasound (NaviFUS) in recurrent glioblastoma; enrollment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: NaviFUS Corporation | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 3 | Status: RECRUITING